Conversion to Sirolimus: Effects in Cytomegalovirus Infection Recurrence in Kidney Transplant Recipients (StopCMV: S=Sirolimus CMV= Cytomegalovirus)
Latest Information Update: 05 Nov 2021
At a glance
- Drugs Sirolimus (Primary) ; Antithymocyte globulin; Azathioprine; Mycophenolate sodium; Prednisone; Tacrolimus
- Indications Cytomegalovirus infections
- Focus Proof of concept; Therapeutic Use
- Acronyms StopCMV
- 03 Jun 2020 Primary endpoint (Cytomegalovirus infection/disease recurrence) has been met, according to results presented at the 2020 American Transplant Congress.
- 03 Jun 2020 Status changed from recruiting to completed, according to results presented at the 2020 American Transplant Congress.
- 03 Jun 2020 Results assessing whether a conversion to sirolimus after the first episode of CMV infection/disease is associated with reduced incidence of recurrent CMV infection, were presented at the 2020 American Transplant Congress.